Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference
Jazz Pharmaceuticals (Nasdaq: JAZZ) has announced its participation in Citi's 2024 Global Healthcare Conference. The company's management will engage in a fireside chat on December 3, 2024, at 7:15 a.m. PT / 10:15 a.m. ET / 3:15 p.m. GMT. An audio webcast will be available through the company's investor website and archived for 30 days.
Jazz Pharmaceuticals is a global biopharma company focusing on developing life-changing medicines for serious diseases. The company maintains a diverse portfolio of marketed medicines for sleep disorders and epilepsy, along with cancer treatments. Based in Dublin, Ireland, Jazz operates research, development, and manufacturing facilities across multiple countries.
Jazz Pharmaceuticals (Nasdaq: JAZZ) ha annunciato la sua partecipazione alla Global Healthcare Conference 2024 di Citi. La direzione dell'azienda parteciperà a una chiacchierata informale il 3 dicembre 2024, alle 7:15 PT / 10:15 ET / 15:15 GMT. Sarà disponibile un webcast audio sul sito web degli investitori dell'azienda, archiviato per 30 giorni.
Jazz Pharmaceuticals è un'azienda biopharma globale che si concentra sullo sviluppo di farmaci che cambiano la vita per malattie gravi. L'azienda vanta un portafoglio diversificato di farmaci commercializzati per disturbi del sonno ed epilessia, insieme a trattamenti per il cancro. Con sede a Dublino, Irlanda, Jazz gestisce strutture di ricerca, sviluppo e produzione in più paesi.
Jazz Pharmaceuticals (Nasdaq: JAZZ) ha anunciado su participación en la Conferencia Global de Atención Médica 2024 de Citi. La dirección de la empresa participará en una charla informal el 3 de diciembre de 2024, a las 7:15 a.m. PT / 10:15 a.m. ET / 3:15 p.m. GMT. Habrá una transmisión de audio disponible a través del sitio web de inversores de la empresa, que se archivará durante 30 días.
Jazz Pharmaceuticals es una empresa biopharma global que se centra en el desarrollo de medicamentos que cambian la vida para enfermedades graves. La empresa tiene un portafolio diverso de medicamentos comercializados para trastornos del sueño y epilepsia, junto con tratamientos para el cáncer. Con sede en Dublín, Irlanda, Jazz opera instalaciones de investigación, desarrollo y manufactura en varios países.
재즈 제약 (Nasdaq: JAZZ)는 시티의 2024 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2024년 12월 3일 오전 7:15 PT / 오전 10:15 ET / 오후 3:15 GMT에 화로 채팅에 참여할 예정입니다. 오디오 웹캐스트는 회사의 투자자 웹사이트를 통해 제공되며, 30일 동안 아카이브됩니다.
재즈 제약은 심각한 질병에 대한 삶을 변화시키는 의약품 개발에 중점을 둔 글로벌 바이오파마 기업입니다. 이 회사는 수면 장애 및 간질, 그리고 암 치료를 위한 다양하고 상용화된 약물 포트폴리오를 보유하고 있습니다. 아일랜드 더블린에 본사를 두고 있는 재즈는 여러 국가에 연구, 개발 및 제조 시설을 운영하고 있습니다.
Jazz Pharmaceuticals (Nasdaq: JAZZ) a annoncé sa participation à la Conférence mondiale sur la santé 2024 de Citi. La direction de l'entreprise participera à une discussion informelle le 3 décembre 2024 à 7h15 PT / 10h15 ET / 15h15 GMT. Un webinaire audio sera disponible sur le site web des investisseurs de l'entreprise et archivé pendant 30 jours.
Jazz Pharmaceuticals est une entreprise biopharmaceutique mondiale qui se concentre sur le développement de médicaments transformant la vie pour des maladies graves. L'entreprise dispose d'un portefeuille diversifié de médicaments commercialisés pour les troubles du sommeil et l'épilepsie, ainsi que pour les traitements contre le cancer. Basée à Dublin, en Irlande, Jazz exploite des installations de recherche, de développement et de fabrication dans plusieurs pays.
Jazz Pharmaceuticals (Nasdaq: JAZZ) hat seine Teilnahme an der Citi's 2024 Global Healthcare Conference angekündigt. Das Management des Unternehmens wird am 3. Dezember 2024 um 7:15 Uhr PT / 10:15 Uhr ET / 15:15 Uhr GMT an einem informellen Gespräch teilnehmen. Ein Audio-Webcast wird über die Investorenseite des Unternehmens verfügbar sein und für 30 Tage archiviert.
Jazz Pharmaceuticals ist ein globales Biopharma-Unternehmen, das sich auf die Entwicklung lebensverändernder Medikamente für schwerwiegende Krankheiten konzentriert. Das Unternehmen verfügt über ein diverses Portfolio an vermarkteten Medikamenten für Schlafstörungen und Epilepsie sowie über Krebsmittel. Der Hauptsitz befindet sich in Dublin, Irland, und Jazz betreibt Forschungs-, Entwicklungs- und Produktionsanlagen in mehreren Ländern.
- None.
- None.
An audio webcast of the fireside chat will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcast will be archived on the website for 30 days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in
Contacts:
Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-citis-2024-global-healthcare-conference-302310546.html
SOURCE Jazz Pharmaceuticals plc
FAQ
When is Jazz Pharmaceuticals (JAZZ) participating in Citi's 2024 Healthcare Conference?
Where can I watch Jazz Pharmaceuticals' (JAZZ) presentation at Citi's 2024 Healthcare Conference?
What are the main therapeutic areas for Jazz Pharmaceuticals (JAZZ)?
